Could a simple inhaler cut lung complications after cancer surgery?

NCT ID NCT06865040

Recruiting now Disease control Sponsor: Centre Hospitalier Universitaire, Amiens Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether giving an inhaled bronchodilator (formoterol) before and after lung cancer surgery can reduce the number of lung complications, like pneumonia or collapsed lung. The trial includes 266 adults with lung cancer who are at high risk due to low lung function. Participants receive either the inhaled drug or usual care, and the number of complications is checked at day 7 after surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Formoterol fumarate (an inhaled bronchodilator)
What this could lead to: If it works, this could provide a simple way to reduce serious lung complications after lung cancer surgery.
What could go wrong: This is a single-center trial with 266 participants, so results may not apply broadly. The drug is already used for asthma/COPD, so the benefit in this specific setting is unproven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

POSTOPERATIVE PULMONARY COMPLICATIONS (PPCS) THORACIC SURGERY

Contacts and locations

Locations

CHRU Amiens
RECRUITING

Amiens, 80054, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.